Rankings
▼
Calendar
FOLD Q3 2016 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
$5B
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$2M
83.8% margin
Operating Income
-$45M
-2112.8% margin
Net Income
-$47M
-2193.4% margin
EPS (Diluted)
$-0.33
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$41M
Free Cash Flow
-$42M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$918M
Total Liabilities
$582M
Stockholders' Equity
$337M
Cash & Equivalents
$33M
Geographic Segments
European Union
$2M
100%
← FY 2016
All Quarters
Q4 2016 →